InvestorsHub Logo

Joe Kaplan

03/01/22 3:42 PM

#795 RE: Good Stick #794

Unfortunately this info was all known to RLF over a year and a half ago....

Can Neuro get some approvals and be a team player for RLF ???

EVIDENTLY NOT.

georgejjl

03/01/22 8:20 PM

#797 RE: Good Stick #794

Earlier treatment leads to improved outcomes. Aviptadil showed a manageable safety profile, with no unexpected serious adverse events.



https://www.nrxpharma.com/wp-content/uploads/2022/03/ZYESAMI-Clinical-Trial-Results.pdf

Good luck and GOD bless,